Total Valuation
MedGen has a market cap or net worth of $3.01K. The enterprise value is $31.10K.
Market Cap$3.01K
Enterprise Value$31.10K
Share Statistics
MedGen has 3,010,314,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,010,314,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedGen’s return on equity (ROE) is 0.36 and return on invested capital (ROIC) is 81.13%.
Return on Equity (ROE)0.36
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)81.13%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee0.00
Profits Per Employee-5.33
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MedGen is ―. MedGen’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio-725.46
Price to Fair Value-725.46
Price to FCF-2.16K
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, MedGen had revenue of 0.00 and earned ― in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
MedGen pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.00
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
MedGen upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MedGen as a current ratio of 0.00, with Debt / Equity ratio of ―
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap<0.01
Net Debt to EBITDA-1.59
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MedGen has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MedGen EV to EBITDA ratio is -2.02K, with an EV/FCF ratio of -2.16K.
EV to Sales0.00
EV to EBITDA-2.02K
EV to Free Cash Flow-2.16K
EV to Operating Cash Flow-2.16K
Balance Sheet
MedGen has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin―
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MedGen is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―